Mohamad Cherry

674 total citations
55 papers, 386 citations indexed

About

Mohamad Cherry is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Mohamad Cherry has authored 55 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 18 papers in Oncology and 16 papers in Genetics. Recurrent topics in Mohamad Cherry's work include Acute Myeloid Leukemia Research (18 papers), Chronic Lymphocytic Leukemia Research (10 papers) and CAR-T cell therapy research (9 papers). Mohamad Cherry is often cited by papers focused on Acute Myeloid Leukemia Research (18 papers), Chronic Lymphocytic Leukemia Research (10 papers) and CAR-T cell therapy research (9 papers). Mohamad Cherry collaborates with scholars based in United States, Germany and Italy. Mohamad Cherry's co-authors include Sami Ibrahimi, Manish R. Patel, Gary J. Schiller, Jesús G. Berdeja, Jessica K. Altman, Jeffrey Matous, Ian W. Flinn, Brenda Cooper, José C. Cruz and Tara L. Lin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Mohamad Cherry

50 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohamad Cherry United States 11 179 143 124 103 103 55 386
Guru Subramanian Guru Murthy United States 13 338 1.9× 121 0.8× 160 1.3× 137 1.3× 85 0.8× 81 520
Liya Ma China 11 121 0.7× 65 0.5× 93 0.8× 107 1.0× 53 0.5× 39 305
Muhamad Alhaj Moustafa United States 10 88 0.5× 79 0.6× 121 1.0× 50 0.5× 106 1.0× 89 315
Panagiotis Repoussis Greece 10 177 1.0× 227 1.6× 154 1.2× 95 0.9× 174 1.7× 12 436
Velia Bongarzoni Italy 10 238 1.3× 76 0.5× 173 1.4× 115 1.1× 51 0.5× 21 340
Mariana Bastos‐Oreiro Spain 11 136 0.8× 68 0.5× 180 1.5× 46 0.4× 126 1.2× 51 363
Woo‐Sung Min South Korea 14 323 1.8× 119 0.8× 104 0.8× 87 0.8× 40 0.4× 34 451
Mayur Narkhede United States 8 143 0.8× 116 0.8× 131 1.1× 63 0.6× 124 1.2× 40 320
Jessica Hochberg United States 14 92 0.5× 58 0.4× 279 2.3× 76 0.7× 178 1.7× 43 552
Bruce Greig United States 7 151 0.8× 74 0.5× 82 0.7× 83 0.8× 104 1.0× 10 319

Countries citing papers authored by Mohamad Cherry

Since Specialization
Citations

This map shows the geographic impact of Mohamad Cherry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohamad Cherry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohamad Cherry more than expected).

Fields of papers citing papers by Mohamad Cherry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohamad Cherry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohamad Cherry. The network helps show where Mohamad Cherry may publish in the future.

Co-authorship network of co-authors of Mohamad Cherry

This figure shows the co-authorship network connecting the top 25 collaborators of Mohamad Cherry. A scholar is included among the top collaborators of Mohamad Cherry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohamad Cherry. Mohamad Cherry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Boyu, Loretta J. Nastoupil, Houston Holmes, et al.. (2024). A CRISPR-edited allogeneic anti-CD19 CAR-T cell therapy with a PD-1 knockout (CB-010) in patients with relapsed/refractory B cell non-Hodgkin lymphoma (r/r B-NHL): Updated phase 1 results from the ANTLER trial.. Journal of Clinical Oncology. 42(16_suppl). 7025–7025. 9 indexed citations
2.
Pratz, Keith W., Mohamad Cherry, Jessica K. Altman, et al.. (2023). Gilteritinib in Combination With Induction and Consolidation Chemotherapy and as Maintenance Therapy: A Phase IB Study in Patients With Newly Diagnosed AML. Journal of Clinical Oncology. 41(26). 4236–4246. 27 indexed citations
3.
Cherry, Mohamad, et al.. (2023). Gray zone lymphoma: A case report and comprehensive review of literature. Leukemia Research Reports. 19. 100372–100372. 3 indexed citations
4.
5.
6.
Kharfan‐Dabaja, Mohamed A. & Mohamad Cherry. (2020). Hematopoietic Cell Transplant for Blastic Plasmacytoid Dendritic Cell Neoplasm. Hematology/Oncology Clinics of North America. 34(3). 621–629. 12 indexed citations
7.
Flinn, Ian W., Mohamad Cherry, Michael B. Maris, et al.. (2019). Combination trial of duvelisib (IPI‐145) with rituximab or bendamustine/rituximab in patients with non‐Hodgkin lymphoma or chronic lymphocytic leukemia. American Journal of Hematology. 94(12). 1325–1334. 33 indexed citations
8.
Mukherjee, Sarbajit, et al.. (2018). Granulocytic sarcoma and mediastinal germ cell tumor. Hematology/Oncology and Stem Cell Therapy. 12(4). 228–229. 1 indexed citations
9.
Ibrahimi, Sami, et al.. (2017). Incidence of Vascular Thromboembolic Events in Patients Receiving Immunotherapy: A Single Institution Experience. Blood. 130. 4864–4864. 23 indexed citations
10.
Mukherjee, Sarbajit, et al.. (2017). Analysis of Outcome of Patients Treated with Anti PD-1/Pdl-1 Therapy According to the Degree of Lymphopenia. Blood. 130. 3594–3594. 2 indexed citations
11.
12.
Mukherjee, Sarbajit, et al.. (2017). Non-seminomatous mediastinal germ cell tumor and acute megakaryoblastic leukemia. Annals of Hematology. 96(9). 1435–1439. 18 indexed citations
13.
Ibrahimi, Sami, et al.. (2017). Extranodal Marginal Zone Lymphoma of the Central Nervous System. Clinical Lymphoma Myeloma & Leukemia. 18(1). 34–37.e8. 26 indexed citations
14.
Adnan, Md., et al.. (2015). Distant skin metastases as primary presentation of gastric cancer. The Journal of Community and Supportive Oncology. 13(4). 156–158. 3 indexed citations
15.
Anand, Ankit, et al.. (2014). Outcome of Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome According to Health Insurance Status. Clinical Lymphoma Myeloma & Leukemia. 14(6). 509–513. 9 indexed citations
16.
Yang, Jian, et al.. (2014). An unusual presentation of an aggressive spindle cell skin cancer. The Journal of Community and Supportive Oncology. 12(4). 149–152.
17.
Cherry, Mohamad, et al.. (2014). Autoimmune hemolytic anemia and thrombocytopenia attributed to an intrauterine contraceptive device. Transfusion. 55(3). 657–660. 2 indexed citations
18.
Cherry, Mohamad, Marylou Cárdenas-Turanzas, Hagop M. Kantarjian, et al.. (2013). Patients with polycythemia vera and essential thrombocythemia with prior malignancy do not have significantly worse outcome. Leukemia Research. 37(11). 1472–1476. 4 indexed citations
19.
Cherry, Mohamad, et al.. (2012). Ifosfamide-induced neurotoxicity reversal with continuous veno-venous hemodialysis. A case report. Journal of Oncology Pharmacy Practice. 19(3). 261–264. 6 indexed citations
20.
Cherry, Mohamad, et al.. (2011). Standard Therapy for Patients With Myelodysplastic Syndromes. Clinical Lymphoma Myeloma & Leukemia. 11(4). 303–313. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guru Subramanian Guru Murthy Breakdown of academic impact, for papers by Liya Ma Breakdown of academic impact, for papers by Muhamad Alhaj Moustafa Breakdown of academic impact, for papers by Panagiotis Repoussis Breakdown of academic impact, for papers by Velia Bongarzoni Breakdown of academic impact, for papers by Mariana Bastos‐Oreiro Breakdown of academic impact, for papers by Woo‐Sung Min Breakdown of academic impact, for papers by Mayur Narkhede Breakdown of academic impact, for papers by Jessica Hochberg Breakdown of academic impact, for papers by Bruce Greig
Rankless by CCL
2026